Leerink Partnrs Has Negative Outlook of ALDX Q3 Earnings
Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Free Report) – Analysts at Leerink Partnrs decreased their Q3 2025 EPS estimates for Aldeyra Therapeutics in a research note issued on Monday, May 19th. Leerink Partnrs analyst M. Goodman now expects that the biotechnology company will post earnings of ($0.23) per share for the quarter, down from their previous […]
Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Free Report) – Analysts at Leerink Partnrs decreased their Q3 2025 EPS estimates for Aldeyra Therapeutics in a research note issued on Monday, May 19th. Leerink Partnrs analyst M. Goodman now expects that the biotechnology company will post earnings of ($0.23) per share for the quarter, down from their previous […]
